By the time Kapil Grover enrolled in our nutrition program in June 2026, he had already faced substantial nutritional and physical challenges during his cancer journey. He received a colon cancer diagnosis in January 2026, but his symptoms had started months earlier. Stomach problems began in October 2025 and persisted, prompting further investigation. A CT scan revealed several tumors and lesions involving his small and large intestines, leading to extensive surgical and oncological treatment.
His treatment included an ileostomy and the placement of a stoma bag. He underwent surgical removal of the tumor, and his stoma was closed in May 2026. He began his first cycle of chemotherapy on April 23, 2026, but did not tolerate the treatment well. Cancer, surgery, chemotherapy, gastrointestinal problems, and reduced nutritional reserve had a substantial cumulative effect.
Kapil had lost about 22 kg since his diagnosis. By the time he entered our nutrition program on June 3, 2026, he weighed just 55 kg, and his initial laboratory results suggested that his body was struggling to recover:
| Parameter | June 3, 2026 |
|---|---|
| HbA1c | 6.2 percent |
| Hemoglobin | 7.5 g/dL |
| RBC count | 3.23 million/µL |
| ESR | 58 mm/hr |
| Serum albumin | 3.08 g/dL |
| SGOT | 184.2 U/L |
| SGPT | 199 U/L |
| ALP | 680 U/L |
| GGT | 489 U/L |
Our first priority was not to put weight back on the scale. It was to determine what his body needed during that specific phase of treatment.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Going beyond calories
Eating less is rarely the only driver of cancer-related weight loss. Nutritional decline may result from surgery, chemotherapy, inflammation, altered gastrointestinal function, changes in appetite and food tolerance, and increased metabolic demands.
Kapil’s laboratory results also indicated that his physiological and nutritional reserves needed attention. He had low hemoglobin, decreased serum albumin, a considerably elevated ESR, and elevated liver-associated markers.
We therefore treated his nutrition plan not as a general weight-gain program but as part of his supportive cancer care. The plan was tailored to his treatment status, gastrointestinal tolerance, nutritional needs, and ability to consume and digest food comfortably. It emphasized adequate protein and energy intake, nutrient density, hydration, gastrointestinal tolerance, and preservation of lean tissue. Targeted nutritional supplements were also added based on his needs.
The goal was straightforward: Give his body the nutritional building blocks it needed to recover from surgery and tolerate cancer therapy. Nutrition was not intended to replace chemotherapy or surgery. It was a supportive component of his overall care.
After eight weeks
Kapil underwent additional blood tests on August 6, 2026. Several measures changed substantially:
| Parameter | June 3, 2026 | August 6, 2026 | Change |
|---|---|---|---|
| HbA1c | 6.2 percent | 4.5 percent | Decreased 1.7 percentage points |
| Hemoglobin | 7.5 g/dL | 10.2 g/dL | Increased 36 percent |
| RBC count | 3.23 million/µL | 4.20 million/µL | Increased 30 percent |
| ESR | 58 mm/hr | 13 mm/hr | Decreased 78 percent |
| Serum albumin | 3.08 g/dL | 4.1 g/dL | Increased 33 percent |
| SGOT | 184.2 U/L | 19 U/L | Decreased 90 percent |
| SGPT | 199 U/L | 19.4 U/L | Decreased 90 percent |
| ALP | 680 U/L | 77 U/L | Decreased 89 percent |
| GGT | 489 U/L | 24 U/L | Decreased 95 percent |
His weight remained 55 kg, but it was gratifying to see improvements in several measures. His RBC count increased from 3.23 to 4.20 million/µL, and his hemoglobin increased from 7.5 to 10.2 g/dL. His serum albumin rose from 3.08 to 4.1 g/dL, consistent with an improvement in his nutritional status.
His ESR fell from 58 to 13 mm/hr, a substantial decrease in the inflammatory marker. Liver-related markers also improved: ALP fell from 680 to 77 U/L, GGT from 489 to 24 U/L, SGOT from 184.2 to 19 U/L, and SGPT from 199 to 19.4 U/L. His HbA1c fell from 6.2 percent to 4.5 percent.
The significance of these figures and what they don’t mean
It is tempting to see such rapid changes and attribute every improvement to a single intervention. Clinical reality is more complex.
Chemotherapy, surgery, postoperative recovery, medical supervision, nutritional intervention, and the broader cancer treatment plan all played a role in Kapil’s recovery. These variables are inextricably linked, and this case does not imply that the laboratory improvements were due solely to diet or supplements.
The case does, however, highlight the potential importance of addressing nutrition actively during cancer treatment instead of waiting for nutritional decline to worsen. Nutrition should not be an afterthought for patients who are losing substantial weight and facing treatment-related difficulties. It should be assessed, monitored, and adjusted throughout treatment.
Nutritional care in oncology: a new perspective
One of the most important lessons from Kapil’s case is the need for tailored nutritional intervention. A general “healthy diet” is not always sufficient for a patient undergoing chemotherapy and recovering from gastrointestinal surgery. The nutritional plan must consider surgical history, gastrointestinal function, food tolerance, protein needs, weight trajectory, laboratory results, hydration, metabolic status, and current cancer therapy.
The objective is not simply to make a patient eat more. It is to help the patient obtain and use sufficient nutrients while navigating a demanding period of life.
Kapil’s test results from June to August offer a promising illustration of what can occur when nutritional care is purposefully integrated into a broader cancer care plan. Yet no single figure holds the most important lesson.
The lesson is the idea underlying the figures: Cancer treatment focuses on the disease. Nutritional care supports the person experiencing it. Advanced cancer treatment and meaningful nutritional support should not be mutually exclusive. These approaches can and should complement each other.
Kapil’s story reminds medical professionals to ask a second question alongside the diagnosis: How well is the patient being fed while the illness is being treated? Scans and treatment cycles are not the only indicators of recovery. Hemoglobin, albumin, strength, weight stability, gastrointestinal function, metabolic health, and the patient’s ability to rebuild physiological reserve are also important indicators.
Supporting those foundations can sometimes play a meaningful role in helping a patient move forward.
Manjari Chandra is a nutritional medicine physician in India.
